Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02959463 · OUTCOME

Safety/Toxicity

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma · Source last updated 2026-05-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
Baseline to 4-months after the start of radiation therapy

What was measured

To determine the safety and tolerability of pembrolizumab administered after radiation therapy in patients with MPM. The primary endpoint was "unaccepable" high grade adverse events (AEs) from baseline to 4-month after the start of radiation therapy.

Groups in this outcome

Cohort 1

Patient with lung intact to receive hemithoracic radiation therapy for definitive intent

Cohort 2

Patients with lung intact to receive non-hemithoracic radiation therapy(palliative radiation therapy)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Cohort 112
Cohort 212

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cohort 10Not reportedNot reportedNot reportedNot reported
Cohort 20Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        0
denoms
  1. counts
    1. group Id
      OG000
      value
      12
    2. group Id
      OG001
      value
      12
    units
    Participants
description
To determine the safety and tolerability of pembrolizumab administered after radiation therapy in patients with MPM. The primary endpoint was "unaccepable" high grade adverse events (AEs) from baseline to 4-month after the start of radiation therapy.
groups
  1. description
    Patient with lung intact to receive hemithoracic radiation therapy for definitive intent
    id
    OG000
    title
    Cohort 1
  2. description
    Patients with lung intact to receive non-hemithoracic radiation therapy(palliative radiation therapy)
    id
    OG001
    title
    Cohort 2
param Type
NUMBER
reporting Status
POSTED
time Frame
Baseline to 4-months after the start of radiation therapy
title
Safety/Toxicity
type
PRIMARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice